In conclusion, the present study shows that the reduced expression of miR-145 in breast cancer is due to DNA methylation, and miR-145 represses cell migration and invasion by targeting ANGPT2 both in vivo and in vitro. This evidence concerns the gene ANGPT2 and breast cancer.